As of July 2, 2020, the FDA has issued two individual EUAs for antigen diagnostic tests for SARS-CoV-2 that are authorized for use at the POC (the inpatient care settings operating under a CLIA Certificate of Waiver). HCPCS code 87426 describes the testing performed by these two EUA antigen SARS-CoV-2 tests.

2020年10月5日 · HCPCS code 87426 describes the testing performed by these 2 EUA antigen SARS-CoV-2 tests. To be recognized as a test that can be performed in a facility having a CLIA certificate of waiver, the modifier QW must be added.

2023年5月12日 · 87426. Infectious agent antigen detection by immunoassay technique, (e.g., enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative; severe acute respiratory syndrome coronavirus (e.g., SARS-CoV, SARS-CoV …

2024年11月30日 · This article informs you about the addition of the QW modifier to HCPCS code 87426 [ (Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative, multiple-step …

2020年6月29日 · CPT® code 87426 reports infectious agent antigen detection by immunoassay technique of SARS-CoV and SARS-CoV-2, and it will be a child code under parent code 87301. The two new proprietary laboratory analyses (PLA) …

Modifier QW is defined as a Clinical Laboratory Improvement Amendment (CLIA) waived test. Some things to keep in mind when appending modifier QW to your lab service/s: The modifier is used to identify waived tests and must be submitted in the first modifier field. CLIA waived tests requiring the QW modifier are considered simplified analysis tests.

The Current Procedural Terminology (CPT ®) code 87426 as maintained by American Medical Association, is a medical procedural code under the range - Infectious Agent Antigen Detection. Subscribe to Codify by AAPC and get the code details in a flash.

2020年8月10日 · The Medicare contractor shall permit the use of code 87426QW for claims submitted by facilities with a valid, current CLIA certificate of waiver with dates of service on or after June 25, 2020.

Beginning August 13, 2020, for dates of service on or after June 25, 2020, new procedure code 87426 will require modifier QW when billed. Important: Providers must refer to the CMS CLIA website for a complete list of CLIA-waived tests, provider certifications, and billing requirements.

CPT 87426 is used when a healthcare provider orders an immunoassay to detect SARS-CoV-2 antigens in a patient’s blood sample. This code is particularly relevant during outbreaks or when there is a high prevalence of COVID-19 in the community.